Engkang, Humaydi A.

HRN: 22-34-70  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
BENZYL PENICILLIN 5MU (VIAL)
12/22/2022
12/25/2022
INTRAMUSCULAR
2.4 MU
4x Weekly
Immunocompromised, Syphilis, Fistula In Ano
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: